What Design-to-experiment Traceability Means for Labs

Design-to-experiment traceability is the ability to walk from a wet-lab result back to the exact sequence file, oligo set, and design parameters that produced it. If a blot, edit, or cloning failure cannot name a construct version, the lab has a record of activity but not a record of cause.

This article is for molecular biology teams who already generate maps and notebook pages and need those objects to point at each other on purpose.

What Has to Be Linked

A cloning or CRISPR experiment sits on three layers. The design file says what molecule was intended. The physical lot says which DNA or RNA went into the tube. The experiment record says what was done and observed. Traceability is the set of identifiers that join those layers.

Why Copy-Paste FASTA Breaks the Chain

A 20-nt spacer or a gene fragment pasted into chat has no genome build, no parent map, and no primer features. The clone may still work. The next person cannot tell whether they are looking at v2 or v3 when expression fails.

Annotated maps in molecular biology software are the design layer. They should carry CDS translations, primer features, and the assembly method. FASTA exports are for tools that cannot read features, not for the system of record.

How to Implement Traceability Without a Heavy LIMS

Pick a construct ID scheme and do not recycle names. pAC-EGFP-v1 and pAC-EGFP-v2 are different objects even if someone "only changed a tag." Put that ID on the map, the oligo order, the tube, and the ELN page.

When a design parameter matters (genome build for sgRNA, enzyme list for a digest, primer Tm method), store it on the design record, not only in a lab member's memory. For CRISPR, that includes spacer, PAM, and the off-target table that was accepted.

Connected workspaces such as Zettalab are useful when the map and the notebook entry can live in one project with the same ID. The scientific requirement does not depend on a vendor: a reviewer must travel from result to file without asking Slack.

Review Questions That Expose Missing Links

Ask these before a plasmid is declared a lab reagent. Which file was used to order oligos? Which colony and prep lot produced this tube? Which alignment passed? If the expression protein molecular weight is wrong, which tagged translation was intended?

If any answer is "we always use the same one," the chain is already broken. Always is not a version.

FAQ

What is design-to-experiment traceability in a cloning lab?

It is a documented path from an experimental observation back to the sequence design that was supposed to be in the tube. That path includes construct version, oligo or synthesis identifiers, DNA lot, operator, and raw QC files. It is not the same as having many files. It is the same as having those files labeled and cross-referenced. Without it, troubleshooting becomes folklore. With it, a frameshifted tag is visible as a version error rather than a mysterious "expression problem."

Do we need LIMS to get this?

Not necessarily. A LIMS helps when samples and barcodes dominate. Construct-centric labs can get far with versioned maps, a notebook that stores IDs, and a rule that tubes match those IDs. LIMS becomes relevant when you also track every aliquot, freezer slot, and chain of custody for regulated samples. Do not wait for a LIMS purchase to start versioning plasmids. The notebook-plus-map habit is the part that cloning quality actually depends on. If you later add LIMS, keep the same construct IDs so you do not run two naming systems.

How should sgRNA designs be tied to cloning records?

Store spacer, scaffold, promoter class, genome build, scoring snapshot, oligo sequences, destination plasmid version, and the later clone chromatogram under one ID. If the spacer was designed in a web tool and cloned in another, attach both outputs. The wet-lab CRISPR experiment should cite the plasmid lot, not "the BCL2 guide." Connected design and ELN tools reduce copy-paste, but the ID scheme is still a lab policy. When two guides share a backbone, give each cassette its own spacer ID so off-target tables do not get swapped.

What is a good construct versioning rule?

Increment the version when the sequence changes, including silent recoding, tag swaps, and promoter swaps. Do not overwrite. Keep v1 available if v2 fails. Put the version in the file name and in a map comment. If two people edit in parallel, merge as a new version rather than emailing "final_final2." Retired versions stay in the archive; they are how you explain old publications. A version that was used in a paper should be frozen even if the lab later "cleans up" the map cosmetics.

How do we audit this without slowing cloning?

Make the minimum fields mandatory on the template: construct ID, parent file, oligo IDs, lot, and pass/fail alignment. Optional narrative can stay free text. Reviewers check IDs, not prose. A structured documentation workflow is enough if the team actually fills the IDs. Speed comes from not rebuilding lost plasmids, not from skipping names. If a field is unknown, write unknown and the date rather than leaving a blank that looks like "not applicable."

Conclusion

Design-to-experiment traceability is a chain of IDs among map, material, and notebook, not a slogan about digital labs. Freeze construct versions before oligos go out, label lots, and store the alignment that released them. Workspaces that keep sequence tools beside ELN records, including Zettalab, make the chain easier to keep. Put the construct ID on the tube the same day you create the file, then keep that ID unchanged until the sequence itself changes.